Everolimus significantly inhibited cell viability in a dose- and time-dependent fashion and diminished phosphorylation of mTOR in a TT thyroid cancer cell line and cultured human MTCs [12]. The gene discussed is MTOR; the disease is thyroid gland carcinoma.